bromfenac has been researched along with nepafenac in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 11 (61.11) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ernest, P; Gayton, J; Lehmann, R; Raizman, M; Walters, T | 1 |
| Bucci, FA; Waterbury, LD | 3 |
| Erdahl, WE; Gadd, ME; Graff, G; Kumar, J; Lal, N; Pfeiffer, DR; Yanni, JM | 1 |
| Awh, CC; Busbee, BG; Cleary, TS; Daniel, P; Heier, JS; Stoller, GL; Waterbury, LD | 1 |
| Bahrani, H; Fox, JE; Warren, KA | 1 |
| Bucolo, C; Drago, F; Marrazzo, G; Platania, CB; Romano, GL; Salomone, S | 1 |
| Kennedy, J; Singer, DD; Wittpenn, JR | 1 |
| Bom Aggio, F; Bottós, JM; Farah, ME; Rodrigues, EB | 1 |
| Bernini, M; Costagliola, C; De Ferrari, F; Morescalchi, F; Russo, A; Semeraro, F; Turano, R; Vezzoli, S | 1 |
| Kohnen, T | 1 |
| Bansal, R; Gupta, A; Pandav, SS; Ram, J; Sahu, S | 1 |
| Campa, C; Perri, P; Salsini, G | 1 |
| Hieda, O; Inatomi, T; Kayukawa, K; Kinoshita, S; Kitazawa, K; Mori, K; Sotozono, C; Wakimasu, K | 1 |
| Addobbati, R; Agostinis, C; Cecchini, P; Cirigliano, G; D'Aloisio, R; De Giacinto, C; Di Martino, G; Di Nicola, M; Pastore, MR; Radillo, O; Tognetto, D | 1 |
| Chen, X; Li, SS; Wang, HH; Wang, YL; Zhang, DW | 1 |
| Ding, K; Heath, M; McDonald, MC; Murphy, DA; Riaz, KM; Shah, S; Shah, SV | 1 |
2 review(s) available for bromfenac and nepafenac
| Article | Year |
|---|---|
Nonsteroidal Anti-Inflammatory Drugs in the Treatment of Retinal Diseases.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Diclofenac; Humans; Ketorolac; Phenylacetates; Retinal Diseases | 2016 |
Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs and corticosteroid drugs for prevention of cystoid macular edema after cataract surgery.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Betamethasone; Cataract; Cataract Extraction; Dexamethasone; Diclofenac; Fluorometholone; Humans; Macular Edema; Treatment Outcome | 2023 |
10 trial(s) available for bromfenac and nepafenac
| Article | Year |
|---|---|
In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Area Under Curve; Benzeneacetamides; Benzophenones; Biological Availability; Bromobenzenes; Cataract Extraction; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Double-Blind Method; Female; Humans; Ketorolac; Male; Middle Aged; Phenylacetates | 2007 |
Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Biological Availability; Bromobenzenes; Chromatography, High Pressure Liquid; Dinoprostone; Female; Humans; Ketorolac; Male; Mass Spectrometry; Middle Aged; Ophthalmic Solutions; Phenylacetates; Retinal Diseases; Tissue Distribution; Vitrectomy; Vitreous Body | 2009 |
NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzeneacetamides; Benzophenones; Bevacizumab; Bromobenzenes; Diclofenac; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Ketorolac; Macular Edema; Male; Middle Aged; Phenylacetates; Pseudophakia; Retina; Single-Blind Method; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cataract; Double-Blind Method; Female; Humans; Ketorolac; Male; Middle Aged; Phenylacetates | 2011 |
Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Dinoprostone; Double-Blind Method; Female; Humans; Ketorolac; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates | 2011 |
Topical NSAIDs effect on corneal sensitivity.
Topics: Administration, Topical; Adult; Analgesia; Anesthetics, Local; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cornea; Diclofenac; Female; Humans; Ketorolac; Male; Ophthalmic Solutions; Phenylacetates; Sensation | 2015 |
REDUCTION OF VITREOUS PROSTAGLANDIN E2 LEVELS AFTER TOPICAL ADMINISTRATION OF INDOMETHACIN 0.5%, BROMFENAC 0.09%, AND NEPAFENAC 0.1.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Biological Availability; Bromobenzenes; Chromatography, High Pressure Liquid; Dinoprostone; Double-Blind Method; Female; Humans; Indomethacin; Male; Ophthalmic Solutions; Phenylacetates; Prospective Studies; Retinal Diseases; Tissue Distribution; Vitrectomy; Vitreous Body | 2016 |
Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Endophthalmitis; Female; Humans; Intraocular Pressure; Ketorolac; Lens Implantation, Intraocular; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Phenylacetates; Photometry; Postoperative Complications; Prospective Studies; Visual Acuity | 2015 |
Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cataract Extraction; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Macula Lutea; Macular Edema; Male; Ophthalmic Solutions; Phenylacetates; Prospective Studies; Pseudophakia; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2018 |
VITREOUS PROSTAGLANDIN E2 CHANGES AFTER TOPICAL ADMINISTRATION OF DICLOFENAC 0.1%, INDOMETHACIN 0.5%, NEPAFENAC 0.3%, AND BROMFENAC 0.09.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Chromatography, High Pressure Liquid; Diclofenac; Dinoprostone; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Epiretinal Membrane; Female; Humans; Indomethacin; Male; Middle Aged; Ophthalmic Solutions; Phenylacetates; Prospective Studies; Retinal Perforations; Vitrectomy; Vitreous Body | 2020 |
6 other study(ies) available for bromfenac and nepafenac
| Article | Year |
|---|---|
Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Area Under Curve; Benzeneacetamides; Benzophenones; Biological Availability; Bromobenzenes; Cataract Extraction; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Ketorolac; Phenylacetates | 2008 |
Differential effects of non-steroidal anti-inflammatory drugs on mitochondrial dysfunction during oxidative stress.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Celecoxib; Diclofenac; Ketorolac Tromethamine; Male; Membrane Potentials; Mitochondria, Liver; Molecular Structure; Oxidative Stress; Permeability; Phenylacetates; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Temperature; Time Factors | 2009 |
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cyclooxygenase 2; Dinoprostone; Indomethacin; Inflammation; Lipopolysaccharides; Male; Phenylacetates; Rats, Sprague-Dawley; Retina; Retinal Hemorrhage; Uveitis | 2014 |
Treating inflammation after lens surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Endophthalmitis; Humans; Ketorolac; Phacoemulsification; Phenylacetates; Postoperative Complications | 2015 |
Topical non-steroidal anti-inflammatory drugs for the treatment of cystoid macular edema post Descemet's stripping automated endothelial keratoplasty.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Corneal Diseases; Descemet Stripping Endothelial Keratoplasty; Female; Humans; Macula Lutea; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phenylacetates; Postoperative Complications; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2018 |
Fill levels, cost comparisons, and expulsion force requirements of commonly used topical ophthalmic nonsteroidal anti-inflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Costs and Cost Analysis; Diclofenac; Humans; Ketorolac; Ophthalmic Solutions; Prospective Studies | 2023 |